Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026)

Elanco Animal Health's (ELAN) quarterly Other Non-Current Liabilities came in at $467.0 million in Q1 2026, down 4.11% year-on-year from $487.0 million in Q1 2025, and down 20.17% quarter-over-quarter from $585.0 million in Q4 2025.

Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

Elanco Animal Health has disclosed Other Non-Current Liabilities across 10 years of filings, most recently posting $467.0 million for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $467.0 million, down 4.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $467.0 million (down 4.11% YoY), and the FY2025 annual result was $585.0 million, up 93.71% from the prior year.
  • Other Non-Current Liabilities came in at $467.0 million for Q1 2026 at Elanco Animal Health, down from $585.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $638.0 million in Q2 2025 to a low of $225.0 million in Q3 2022.
  • The 5-year median for Other Non-Current Liabilities is $432.0 million (2023), against an average of $414.6 million.
  • Across the five-year window, Other Non-Current Liabilities declined 26.52% in 2024 and soared 93.71% in 2025, its largest moves.
  • Elanco Animal Health's Other Non-Current Liabilities stood at $229.0 million in 2022, then soared by 79.48% to $411.0 million in 2023, then slipped by 26.52% to $302.0 million in 2024, then jumped by 93.71% to $585.0 million in 2025, then declined by 20.17% to $467.0 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $467.0 million (Q1 2026), $585.0 million (Q4 2025), and $607.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 467.00 Mn
Dec 31, 2025 585.00 Mn
Sep 30, 2025 607.00 Mn
Jun 30, 2025 638.00 Mn
Mar 31, 2025 487.00 Mn
Dec 31, 2024 302.00 Mn
Sep 30, 2024 587.00 Mn
Jun 30, 2024 465.00 Mn
Mar 31, 2024 474.00 Mn
Dec 31, 2023 411.00 Mn
Sep 30, 2023 432.00 Mn
Jun 30, 2023 411.00 Mn
Mar 31, 2023 245.00 Mn
Dec 31, 2022 229.00 Mn
Sep 30, 2022 225.00 Mn
Jun 30, 2022 242.00 Mn
Mar 31, 2022 242.00 Mn
Dec 31, 2021 262.00 Mn
Sep 30, 2021 220.00 Mn
Jun 30, 2021 237.00 Mn